MannKind Corporation (MNKD) Revenue Growth
MannKind Corporation (MNKD) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -93.28% |
| 2018-12-31 | 137.20% |
| 2019-12-31 | 126.28% |
| 2020-12-31 | 3.34% |
| 2021-12-31 | 15.81% |
| 2022-12-31 | 32.25% |
| 2023-12-31 | 99.42% |
| 2024-12-31 | 43.50% |
| 2025-12-31 | 22.23% |
How MNKD compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| KURA | Kura Oncology Inc. | 25.24% |
| NBIX | Neurocrine Biosciences Inc. | 21.45% |
| INCY | Incyte Corporation | 21.22% |
| AXGN | Axogen Inc. | 20.21% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
These are five companies in the same sector as MNKD with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get MannKind Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("MNKD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MNKD | $3.98 | -0.75% | 2.23M |
| 3 | ||||
| 4 | ||||
| 5 |